GLOW
GLOW is a multi-peptide research blend pairing a high proportion of GHK-Cu with BPC-157 and TB-500, studied for skin, hair, nail, and tissue-repair support; research protocols typically start near 10 units and build to about 30 units (~5 mg GHK-Cu) daily subcutaneously.
It has been studied in research settings for skin, hair, and nail support and for general tissue repair, reflecting GHK-Cu's collagen- and follicle-related research alongside BPC-157 and TB-500's preclinical tissue-repair literature.
GLOW is a multi-peptide research blend; its formulation pairs a high proportion of GHK-Cu (glycyl-L-histidyl-L-lysine bound to copper(II)) with the repair peptides BPC-157 and TB-500. GHK-Cu is a naturally occurring copper-binding tripeptide present in human plasma that declines with age; in cell and animal research it has been characterized as a modulator of skin remodeling, where it has been studied for stimulating fibroblast synthesis of collagen, elastin, and glycosaminoglycans and for regulating matrix metalloproteinases and their inhibitors (TIMP-1, TIMP-2), alongside reported anti-inflammatory and antioxidant gene-level effects. BPC-157, a synthetic 15-amino-acid fragment derived from a gastric protein, has been studied preclinically for tendon, muscle, and ligament repair via angiogenic and nitric-oxide-pathway mechanisms, while TB-500 (a synthetic thymosin beta-4 fragment) has been examined for cell migration and tissue regeneration.
None of these peptides is FDA-approved; each is used as a research compound, and human clinical evidence remains limited.
In research contexts blends of this type are typically administered as a daily or several-times-weekly subcutaneous injection, with conservative starting amounts that account for the combined dose of all three peptides rather than each individually.
Research on the individual components describes gradual changes, with skin- and collagen-related GHK-Cu effects characterized over several weeks of repeated exposure and repair endpoints for BPC-157 and TB-500 likewise reported over multi-week study periods.
Within this product the peptides are already combined, and in broader research practice GHK-Cu, BPC-157, and TB-500 are commonly grouped with recovery- and regeneration-oriented compounds rather than added to further stimulatory agents.
Log every dose, count every vial, and verify your batches — free in the goodtides app.
This page is educational reference material about compounds studied in research settings. It is not medical advice, and nothing here is a recommendation to buy, possess, or use any compound. Research findings described are from published literature; individual compounds may not be approved for human use. Talk to a licensed clinician about anything that affects your health.